NLS Pharmaceutics AG at LD Micro Microcap Invitational Conference (Virtual) Transcript
Welcome to NLS Pharmaceuticals. They are seeking to design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Their aim is to improve quality of life and longevity. They are seeking to create new approaches to treat mental and behavioral disorders and to enhance cognitive function in healthy people.
Alexander Zwyer is the Founder and CEO of NLS Pharmaceuticals. Take it away, Alexander.
Thank you, Erik. Thank you, Alexa. Happy to be with you here. Alex Zwyer, CEO of NLS Pharmaceutics. I'm also a Co-founder of the company. We'll talk to you today about our lead asset, Quilience, that we are developing for narcolepsy. I will be making forward-looking statements, so you are advised to look into our SEC filings, either on the SEC web page or on our web page, nlspharma.com.
We are a Swiss CNS company focusing on rare neurological disorders. Our lead product candidate is called Quilience. Drug substance is called mazindol
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |